Browse by Audience
Skip to content
Papers of the Week
Efficacy and Safety of Aflapin®, a Novel Extract, in the Treatment of Osteoarthritis of the Knee: A Short-Term 30-Day Randomized, Double-Blind, Placebo-Controlled Clinical Study.
Abstract
Aflapin, also known as AprèsFlex was developed as an enhanced bioavailable extract of gum resin, standardized to 20% 3-O-acetyl-11-keto-β-boswellic acid. This randomized, double-blind, placebo-controlled clinical trial confirms the efficacy of Aflapin in ameliorating the symptoms of osteoarthritis (OA) of the knee.